Advertisement Press Releases Archive - Page 3 of 233 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Pressreleases

  • LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

    LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality and cost-competitive large-scale manufacturing capacities.

  • Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds

    Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, achieved solid results and continued to grow profitably in financial year 2024. Revenues reached €2,035.9m (2023: €1,990.5m), while adjusted EBITDA amounted to €419.4m (2023: €404.5m). Organic sales grew by +2.9% and adjusted EBITDA by +4.1%. The adjusted EBITDA margin improved to 20.6% (2023: 20.3%).

  • Two Stories, One Future: Gerresheimer and Bormioli Pharma at Pharmapack 2025

    Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, is presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions for the first time together with Bormioli Pharma at this year's Pharmapack. The focus of the trade show appearance in Paris on 22 and 23 January 2025 will be on the further expanded portfolio of containment solutions with numerous closure options and accessories following the acquisition of Bormioli Pharma.

  • Gerresheimer Successfully Completes Acquisition of Blitz LuxCo, the Holding Company of the Bormioli Pharma Group

    Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech and cosmetics industries, has successfully completed the acquisition of Blitz LuxCo, the holding company of the Bormioli Pharma Group announced in May 2024. The closing was preceded by the fulfillment of customary closing conditions. Bormioli Pharma has a portfolio of pharmaceutical primary packaging made of glass and plastic as well as closure solutions, accessories and dosing systems that is complementary to Gerresheimer.

  • Gerresheimer Builds New Production Capacities for Glass Syringes at Skopje Site

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetics industries, is expanding its production capacity in Skopje, North Macedonia, with a new production hall for syringes. Since 2019, Gerresheimer has been producing drug delivery systems, diagnostic and medical products made of plastic on around 14,600m² at this site. The new factory hall adds around 7,600m² of production space for glass syringes.

  • Gerresheimer Gx Elite Vials: Best Drug Protection and Production Efficiency

    Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, is presenting Gx Elite vials, designed to maximise patient safety and production efficiency through a quality by design approach. The main advantages of the product are its superior quality, which is reflected, for example, in its high breakage resistance and production efficiency. The advanced primary packaging solution is particularly suitable for sophisticated drugs such as biopharmaceuticals and innovative vaccines. Gx Elite vials can be delivered in bulk or pre-sterilised ready-to-fill in Gerresheimer’s innovative EZ-fill Smart packaging.